ARIH2 and hepatocellular carcinoma: Additionally, our data reveal that both mRNA and protein expressions of ARIH2 are elevated in HCC tissues and are associated with adverse clinicopathological characteristics, such as pathologic stage, TNM stage, histologic grade, AFP levels, and vascular invasion.